Showing results (71-80 of 82) with videos related to
Sort By:
Pageof 9
Bioscience Reports|December 18, 2023
Uncovering the essential roles of glutamate carboxypeptidase 2 orthologs in Caenorhabditis elegansLucie Panska, Stepanka Nedvedova, Vojtech Vacek, et al.Journal of Chemical Information and Modeling|January 15, 2024
Structural, Biochemical, and Computational Characterization of Sulfamides as Bimetallic Peptidase InhibitorsZora Novakova, Zahra Aliakbar Tehrani, Radek Jurok, et al.Bioorganic & Medicinal Chemistry|December 16, 2018
Structural and computational basis for potent inhibition of glutamate carboxypeptidase II by carbamate-based inhibitorsCyril Barinka, Zora Novakova, Niyada Hin, et al.Journal of Medicinal Chemistry|April 14, 2016
Unprecedented Binding Mode of Hydroxamate-Based Inhibitors of Glutamate Carboxypeptidase II: Structural Characterization and Biological ActivityZora Novakova, Krystyna Wozniak, Andrej Jancarik, et al.Scientific Reports|April 18, 2019
Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cellsTessa Knox, Eva Sahakian, Debarati Banik, et al.Angiogenesis|July 9, 2016
Prostate-specific membrane antigen (PSMA)-mediated laminin proteolysis generates a pro-angiogenic peptideRebecca E Conway, Camilo Rojas, Jesse Alt, et al.Scientific Reports|October 11, 2019
Author Correction: Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cellsTessa Knox, Eva Sahakian, Debarati Banik, et al.Cancer Letters|March 22, 2025
CUL4A exhibits tumor-suppressing role via regulation of HUWE1-mediated SMAD3 intracellular shuttlingVeronika Danek, Jolana Tureckova, Kerstin Huebner, et al.Journal of Medicinal Chemistry|May 29, 2026
Macrophage-Centric Phenotypic Screening Identifies Tetrazolone-Based HDAC6 Inhibitors That Reprogram the Tumor Immune Microenvironment and Improve Immune Checkpoint BlockadeNithya Gajendran, Manasa Suresh, Sebastian J Marquez R, et al.International Journal of Molecular Sciences|January 11, 2022
Synthesis, Molecular Docking and Biological Characterization of Pyrazine Linked 2-Aminobenzamides as New Class I Selective Histone Deacetylase (HDAC) Inhibitors with Anti-Leukemic ActivityHany S Ibrahim, Mohamed Abdelsalam, Yanira Zeyn, et al.Pageof 9